Novo Nordisk A/SNVONYSE
Loading
EPS Diluted Over TimeStrong
Percentile Rank100
3Y CAGR+23.5%
5Y CAGR+20.6%
Studio
Year-over-Year Change

Diluted earnings per share

3Y CAGR
+23.5%/yr
vs +11.3%/yr prior
5Y CAGR
+20.6%/yr
Consistent
Acceleration
+12.2pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
2.6x
Strong expansion
Streak
9 yr
Consecutive growthStrong
PeriodValueYoY Change
202523.03+1.8%
202422.63+21.5%
202318.62+52.4%
202212.22+17.8%
202110.37+15.1%
20209.01+10.0%
20198.19+2.8%
20187.97+3.5%
20177.70+2.9%
20167.48-